ATTENTION: The software behind KU ScholarWorks is being upgraded to a new version. Starting July 15th, users will not be able to log in to the system, add items, nor make any changes until the new version is in place at the end of July. Searching for articles and opening files will continue to work while the system is being updated.
If you have any questions, please contact Marianne Reed at mreed@ku.edu .
Structure-Based Exploration and Exploitation of the S4 Subsite of Norovirus 3CL Protease in the Design of Potent and Permeable Inhibitors
dc.contributor.author | Kankanamalage, Anushka C. Galasiti | |
dc.contributor.author | Rathnayake, Athri D. | |
dc.contributor.author | Damalanka, Vishnu C. | |
dc.contributor.author | Weerawarna, Pathum M. | |
dc.contributor.author | Doyle, Sean T. | |
dc.contributor.author | Alsoudi, Amer F. | |
dc.contributor.author | Dissanayake, D. M. Padmasankha | |
dc.contributor.author | Groutas, William C. | |
dc.contributor.author | Kim, Yunjeong | |
dc.contributor.author | Chang, Kyeong-Ok | |
dc.contributor.author | Lushington, Gerald H. | |
dc.contributor.author | Mehzabeen, Nurjahan | |
dc.contributor.author | Lovell, Scott | |
dc.contributor.author | Battaile, Kevin P. | |
dc.date.accessioned | 2017-08-30T16:40:39Z | |
dc.date.available | 2017-08-30T16:40:39Z | |
dc.date.issued | 2017-01-27 | |
dc.identifier.citation | Galasiti Kankanamalage, A. C., Kim, Y., Rathnayake, A. D., Damalanka, V. C., Weerawarna, P. M., Doyle, S. T., … Groutas, W. C. (2017). Structure-Based Exploration and Exploitation of the S4 Subsite of Norovirus 3CL Protease in the Design of Potent and Permeable Inhibitors. European Journal of Medicinal Chemistry, 126, 502–516. http://doi.org/10.1016/j.ejmech.2016.11.027 | en_US |
dc.identifier.uri | http://hdl.handle.net/1808/24876 | |
dc.description.abstract | Human noroviruses are the primary cause of epidemic and sporadic acute gastroenteritis. The worldwide high morbidity and mortality associated with norovirus infections, particularly among the elderly, immunocompromised patients and children, constitute a serious public health concern. There are currently no approved human vaccines or norovirus-specific small-molecule therapeutics or prophylactics. Norovirus 3CL protease has recently emerged as a potential therapeutic target for the development of anti-norovirus agents. We hypothesized that the S4 subsite of the enzyme may provide an effective means of designing potent and cell permeable inhibitors of the enzyme. We report herein the structure-guided exploration and exploitation of the S4 subsite of norovirus 3CL protease in the design and synthesis of effective inhibitors of the protease. | en_US |
dc.publisher | Elsevier | en_US |
dc.rights | © 2017. This article is made available under an Attribution-NonCommercial-NoDerivs 3.0 Unported (CC BY-NC-ND 3.0) license. | en_US |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/3.0/ | en_US |
dc.subject | Norovirus | en_US |
dc.subject | 3CL protease | en_US |
dc.subject | S4 subsite | en_US |
dc.subject | Optimization | en_US |
dc.title | Structure-Based Exploration and Exploitation of the S4 Subsite of Norovirus 3CL Protease in the Design of Potent and Permeable Inhibitors | en_US |
dc.type | Article | en_US |
kusw.kuauthor | Mehzabeen, Nurjahan | |
kusw.kuauthor | Lovell, Scott | |
kusw.kudepartment | Protein Structure Laboratory | en_US |
dc.identifier.doi | 10.1016/j.ejmech.2016.11.027 | en_US |
kusw.oaversion | Scholarly/refereed, author accepted manuscript | en_US |
kusw.oapolicy | This item meets KU Open Access policy criteria. | en_US |
dc.identifier.pmid | PMC5501333 | en_US |
dc.rights.accessrights | openAccess |